A Hostile Takeover Of US FDA?

 
• By Michael McCaughan

The expected nominee for FDA commissioner has not been very kind to the agency in his public statements and President-elect Donald Trump appears to be urging him to shake things up.

Expected FDA Commissioner nominee Martin Makary has questioned the FDA staff work ethic and review times. (Screenshot)
Michael McCaughan

Read more by Michael McCaughan

Michael McCaughan is a founding member of Prevision Policy LLC, a leading provider of regulatory and reimbursement policy analysis for the biopharma industry. He was previously the Editor-In-Chief of The Pink Sheet and remains a contributor to the publication.

More from US FDA

More from Legislation